Wen Hung Huang
Direktor/Vorstandsmitglied bei GLORY BIOTECH CO LTD
Profil
Wen Hung Huang is currently the Vice Chairman at Glory Biotech Co., Ltd.
and the Director at Panion & BF Biotech, Inc. He previously worked as a Member-Supervisory Board at Advanced Echem Materials Co., Ltd.
Dr. Huang holds a graduate and doctorate degree from the University of Minnesota, an undergraduate degree from National Taiwan University, and an undergraduate degree from Christ's College.
Aktive Positionen von Wen Hung Huang
| Unternehmen | Position | Beginn |
|---|---|---|
| GLORY BIOTECH CO LTD | Direktor/Vorstandsmitglied | 27.06.2016 |
| PANION & BF BIOTECH INC. | Direktor/Vorstandsmitglied | 03.06.2016 |
Ehemalige bekannte Positionen von Wen Hung Huang
| Unternehmen | Position | Ende |
|---|---|---|
| ADVANCED ECHEM MATERIALS COMPANY LIMITED | Direktor/Vorstandsmitglied | - |
Ausbildung von Wen Hung Huang
| Christ's College | Undergraduate Degree |
| University of Minnesota | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADVANCED ECHEM MATERIALS COMPANY LIMITED | Process Industries |
| PANION & BF BIOTECH INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Glory Biotech Co., Ltd.
 Glory Biotech Co., Ltd. BiotechnologyHealth Technology Glory Biotech Co., Ltd. is engaged in the development, production, and sale of Active Pharmaceutical Ingredients (APIs) and health foods from microorganism. It focused on microbial strain improvement and scale up of fermentation process, production of APIs and the intermediates of API, agriculture biological agent, animal feed ingredient, health foods ingredients, and health food finish products. It products include Functional & Composite Probiotic Powder, Mycophenolic Acid, Daptomycin, Doxorubicin, Epothilone B, Rapamycin, CMS, and GLP-1. The company was founded on October 11, 2000 and is headquartered in Chiayi, Taiwan. | Health Technology |
